CLASS II Drug recall · Reported 5 Sep 2018 · FDA Enforcement Report

Amlodipine/Valsartan/HCTZ 10mg/320mg/25mg Tablet recalled

RemedyRepack is recalling Amlodipine/Valsartan/HCTZ 10mg/320mg/25mg Tablet, distributed in South Carolina. The recall was initiated on 20 Aug 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes70518-1220-0; Lot #: B0476653-080218; Exp. Date: 08/2019
Quantity recalled3 bottles of 90 tablets (270 tablets overall)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1146-2018
FDA event ID
80891
Recalling firm
RemedyRepack, Indiana, PA
Classification
Class II
Status
Terminated
Recall initiated
20 Aug 2018
FDA classified
28 Aug 2018
Reported
5 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Nitrosamine Impurity

Timeline

20 Aug 2018Recall initiated by company
28 Aug 2018Classified by FDA+8 days
5 Sep 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.

Nitrosamines are impurities that can form during drug manufacturing or storage. Above the FDA acceptable intake limit, long-term exposure may raise cancer risk. The FDA advises patients to keep taking the medicine until they have a replacement.

Product as listed by the FDA

Amlodipine/Valsartan/HCTZ 10mg/320mg/25mg Tablet, Rx Only (HDPE 90cc Bottles in cardboard trays) MFG Torrent Pharma LTD, Indrad, India 38272, NDC #70518-1220-0

Where it was distributed

South Carolina

South Carolina

Questions about this recall

Why was it recalled?

CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.

Which lots are affected?

70518-1220-0; Lot #: B0476653-080218; Exp. Date: 08/2019

Where was it sold?

South Carolina

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from RemedyRepack

All 61

Other Amlodipine recalls

All 81
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan MedoxomilAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIAmlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan MedoxomilAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIAmlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg recalledAmlodipine And Olmesartan MedoxomilAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIAmlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg recalledAmlodipine Besylate And Benazepril HydrochlorideLupin PharmaceuticalsOtherNationwide
DrugCLASS IIIAmlodipine Besylate Tablets, USP 10 mg recalled by Lupin PharmaceuticalsAmlodipine BesylateLupin PharmaceuticalsPotency & AssayNationwide